Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis

American Journal of Pathology

Volumn 157, Issue 4, 2000, Pages 1155-1166

  Roelofs, Helene ^a   Mostert, Marijke C ^a   Pompe, Kirsten ^a,b   Zafarana, Gaetano ^a   Van Oorschot, Monique ^a   Van Gurp, Ruud J H L M ^a   Gillis, Ad J M ^a   Stoop, Hans ^a   Beverloo, Berna ^c   Oosterhuis, J Wolter ^a   Bokemeyer, Carsten ^b   Looijenga, Leendert H J ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADULT; AGE; APOPTOSIS; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CHROMOSOME 12P; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; MALE; NON SEMINOMATOUS GERMINOMA; ONCOGENE RAS; PRIORITY JOURNAL; SEMINOMA; TREATMENT OUTCOME;

EID: 0033819741     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64631-7     Document Type: Article

References (70)

1. The multistep nature of cancer
2. Immunopathology of germ cell tumors of the testis
3. Possible carcinoma-in-situ of the testis
4. Expression of immunohistochemical markers for testicular carcinoma in situ by normal fetal germ cells
5. Ultrastructure of developing and malignant germ cells
6. i(12p): Specific chromosomal marker in seminoma and malignant teratoma of the testis?
7. Reviews of chromosome studies in urological tumors. 3. Cytogenetics and genes in testicular tumors
8. Isochromosome of chromosome 12: Clinically useful marker for male germ cell tumors
9. The use of tumor markers in germ cell malignancies
10. Quantification of additional short arms of chromosome 12 in germ cell tumors using polymerase chain reaction
11. 2 without point-mutational activation
12. Aberrant expression of cyclin D2 is an early event in human male germ cell tumori-genesis
13. A genetic perspective of male germ cell tumors
14. N-Ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis
15. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung
16. Ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent
17. Essential role for oncogenic Ras in tumour maintenance
18. Creation of human tumour cells with defined genetic elements
19. Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability
20. Disruption of epithelial cell-matrix interactions induces apoptosis
21. Correlation between Ha-ras gene amplification and spontaneous metastasis in NIH 3T3 cells transfected with genomic DNA from human skin cancers
22. NIH3T3 transfectant containing human K-ras oncogene shows enhanced metastatic activity after in vivo tumor growth or co-culture with fibroblasts
23. Ras gene amplification and malignant transformation
24. Transformation and stimulation of DNA synthesis in NIH-3T3 cells are a titratable function of normal p21N-ras expression
25. Frequent overexpression, but not activation by point mutation, of ras genes in primary human gastric cancers
26. Amplification and rearrangement of the Kirsten ras oncogene in virus-transformed BALB/c 3T3 cells during malignant tumor progression
27. Overexpression of c-K-ras, c-N-ras and transforming growth factor beta co-segregate with tumorigenicity in morphologically transformed C3H 10T1/2 cell lines
28. High-level expression of H-ras and c-myc oncogenes in mycoplasma-mediated malignant cell transformation
29. Treatment strategies in metastatic testicular cancer
30. Increased resistance to cis-diamminedichloroplatinum(II) in NIH3T3 cells transformed by ras oncogenes
31. The ras oncogenes increase the intrinsic resistance of NIH3T3 cells to ionizing radiation
32. Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin
33. Ras mutation and platinum resistance in human ovarian carcinomas in vitro
34. Resistance to 195mPt-radiolabeled cis-diaminedichloroplatinum (II) of SHOK cells transfected with various oncogenes
35. Detection of preferential NRAS mutations in human male germ cell tumors by the polymerase chain reaction
36. Detection of ras mutations in archival testicular germ cell tumors by polymerase chain reaction and oligonucleotide hybridization
37. N- and KRAS mutations in human testicular germ cell tumors: Incidence and possible biological implications
38. Heterogeneity in the in vitro survival and proliferation of human seminoma cells
39. Apoptosis of human seminoma cells upon disruption of their micro-environment
40. Detection of vital germ cell tumor cells in short-term cell cultures of primary tumors and of retroperftoneal metastasis - Clinical implications
41. Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia
42. Amplification of chromosome subregion 12p11.2-p12.1 in a metastasis of an i(12p)-negative seminoma: Relationship to tumor progression?
43. Comparative genomic hybridization of germ cell tumors of the adult testis: Confirmation of karyotypic findings and identification of a 12p-amplicon
44. Detection of chromosomal DNA gains and losses in testicular germ cell tumors by comparative genomic hybridization
45. Identification of the crucial region of 12p overrepresentation in testicular germ cell tumors of adolescents and adults
46. Aberrant platelet-derived growth factor α-receptor transcript as a diagnostic marker for early human germ cell tumors of the adult testis
47. Hydrated autoclave pretreatment enhances tau immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues
48. Chromosomal changes in human primary testicular nonseminomatous germ cell tumors
49. Cytogenetic analysis of ten human seminomas (two of them lacking the i(12p))
50. Chromosomal constitution of human spermatocytic seminomas: Comparative genomic hybridization supported by conventional and interphase cytogenetics
51. Comparative genomic hybridization with lissamine- and fluorescein-labelled nucleotides
52. Chromosomal gains and losses in testicular germ cell tumors of adolescents and adults investigated by a modified CGH approach
53. Prognostic significance of K-ras mutations in colorectal carcinoma
54. Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification
55. No recurrent structural abnormalities in germ cell tumors of the adult testis apart from i(12p)
56. Translocations of chromosome 12. II. A comparison of the distribution of sites of spontaneous and induced breakages
57. Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors
58. A comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumors
59. Inhibition of fas (CD95) expression and fas-mediated apoptosis by oncogenic ras
60. Oncogenic Ras inhibits Fas Iigand-mediated apoptosis by downregulating the expression of Fas
61. The akt kinase: Molecular determinants of oncogenicity
62. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
63. Is isochromosome i(12p) present in gonadal precancerous tissue?
64. Cytogenetics of carcinoma in situ of the testis
65. Comparative genomic hybridization of microdissected samples from different stages in the development of a seminoma and nonseminoma